Otonomy Partners with Kyorin Pharmaceutical on Hearing Loss Compound

Under the terms of the agreement, Otonomy will make an upfront payment to Kyorin as well as success-based milestone payments and royalties on worldwide net sales of a product containing the patent-protected compound.